First phase insulin release and glucose tolerance in children with Fanconi anemia after hematopoietic cell transplantation

Pediatric Blood and Cancer

Volumn 53, Issue 2, 2009, Pages 191-196

  Polgreen, Lynda E ^a   Thomas, William ^b   MacMillan, Margaret L ^a   Wagner, John E ^a   Moran, Antoinette ^a   Petryk, Anna ^a,c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Bone marrow transplantation; Fanconi anemia; Glucose intolerance; Insulin resistance; Insulin secretion; IVGTT; OGTT

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID; STEROID;

ADOLESCENT; ARTICLE; BLOOD PRESSURE; BODY FAT; BODY MASS; CHILD; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; FANCONI ANEMIA; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INSULIN METABOLISM; INSULIN RELEASE; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID BLOOD LEVEL; MALE; MEDICAL SCHOOL; METABOLIC DISORDER; ORAL GLUCOSE TOLERANCE TEST; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES; DIABETES MELLITUS; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; METABOLISM; RISK FACTOR;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FANCONI ANEMIA; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INSULIN; MALE; RISK FACTORS;

EID: 67649921580     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22043     Document Type: Article

References (21)

1. Nilsson LR. Chronic pancytopenia with multiple congenital abnormalities (Fanconi's anaemia). Acta Paediatr 1960;49:518-529.
2. Baker KS, Ness KK, Steinberger J, et al. Diabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: A report from the bone marrow transplantation survivor study. Blood 2007;109:1765-1772. (Pubitemid 46239613)
3. Bonanomi S, Gaiero A, Masera N, et al. Distinctive characteristics of diabetes mellitus after hematopoietic cell transplantation during childhood. Pediatr Transplant 2006;10:461-465. (Pubitemid 43780679)
4. Hoffmeister PA, Storer BE, Sanders JE. Diabetes mellitus in longterm survivors of pediatric hematopoietic cell transplantation. J Pediatr Hematol Oncol 2004;26:81-90. (Pubitemid 38186261)
5. Lorini R, Cortona L, Scaramuzza A, et al. Hyperinsulinemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplant 1995;15:873-877.
6. Neville KA, Cohn RJ, Steinbeck KS, et al. Hyperinsulinemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: Prevalence and risk factors. J Clin Endocrinol Metab 2006;91:4401-4407. (Pubitemid 44833416)
7. Taskinen M, Saarinen-Pihkala UM, Hovi L, et al. Impaired glucose tolerance and dyslipidaemia as late effects after bonemarrow transplantation in childhood. Lancet 2000;356:993-997.
8. Traggiai C, Stanhope R, Nussey S, et al. Diabetes mellitus after bone marrow transplantation during childhood. Med Pediatr Oncol 2003;40:128-129. (Pubitemid 35471382)
9. Elder DA, D'Alessio DA, Eyal O, et al. Abnormalities in glucose tolerance are common in children with Fanconi anemia and associated with impaired insulin secretion. Pediatr Blood Cancer 2008;51:256-260. (Pubitemid 351874422)
10. Morrell D, Chase CL, Kupper LL, et al. Diabetes mellitus in ataxiatelangiectasia, Fanconi anemia, xeroderma pigmentosum, common variable immune deficiency, and severe combined immune deficiency families. Diabetes 1986;35:143-147. (Pubitemid 16121530)
11. Wajnrajch MP, Gertner JM, Huma Z, et al. Evaluation of growth and hormonal status in patients referred to the International Fanconi Anemia Registry. Pediatrics 2001;107:744-754. (Pubitemid 32268460)
12. Giri N, Batista DL, Alter BP, et al. Endocrine abnormalities in patients with Fanconi anemia. J Clin Endocrinol Metab 2007;92: 2624-2631. (Pubitemid 47037367)
13. Chase HP, Cuthbertson DD, Dolan LM, et al. First-phase insulin release during the intravenous glucose tolerance test as a risk factor for type 1 diabetes. J Pediatr 2001;138:244-249. (Pubitemid 32156441)
14. Vardi P, Crisa L, Jackson RA. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients. Diabetologia 1991;34:93-102.
15. Bingley PJ, Colman P, Eisenbarth GS, et al. Standardization of IVGTT to predict IDDM. Diabetes Care 1992;15:1313-1316.
16. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31:S55-S60.
17. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
18. Uwaifo GI, Fallon EM, Chin J, et al. Indices of insulin action, disposal, and secretion derived from fasting samples and clamps in normal glucose-tolerant black and white children. Diabetes Care 2002;25:2081-2087.
19. Rothschild CB, Freedman BI, Hodge R, et al. Fructose-1,6- bisphosphatase: Genetic and physical mapping to human chromosome 9q22.3 and evaluation in non-insulin-dependent diabetes mellitus. Genomics 1995;29:187-194.
20. Derr RL, Hsiao VC, Saudek CD. Antecedent hyperglycemia is associated with an increased risk of neutropenic infections during bone marrow transplantation. Diabetes Care 2008;31:1972-1977.
21. d'Annunzio G, Bonetti F, Locatelli F, et al. Insulin resistance in children and adolescents after bone marrow transplantation for malignancies. Haematologica 2006;91:ELT12; author reply ELT13.